ストックスクリーナーアプリを入手
506.85
1.03%
-2.71
Idexx Laboratories Inc (IDXX) 最新ニュース
IDXX - Finviz
IDEXX Laboratories stock gains as analysts lift targets - ad-hoc-news.de
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch
IDEXX Laboratories stock reacts to insider share sale and recent earnings strength - ad-hoc-news.de
Engaging In Options Activity, Lawrence D Kingsley Exercises Options Valued At $873K In IDEXX Laboratories - Benzinga
Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock - The Motley Fool
Is IDEXX Laboratories Stock Underperforming the Dow? - inkl
Idexx Laboratories stock hits 52-week low at $517.00 By Investing.com - Investing.com Australia
IDEXX Laboratories (IDXX) director exercises options and sells 2,203 shares - Stock Titan
Idexx Laboratories stock hits 52-week low at $517.00 - investing.com
IDEXX Laboratories stock heads into the open after a modest gain - ad-hoc-news.de
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
IDEXX Laboratories stock holds near recent highs as diagnostics demand supports growth - ad-hoc-news.de
Down 16% in the Last 12 Months, Can IDEXX Stock Bounce Back in 2027? - TIKR.com
Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030 - GlobeNewswire Inc.
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring A 30% Upside Potential - DirectorsTalk Interviews
IDEXX Laboratories stock gains after strong Q2 results and raised 2026 outlook - ad-hoc-news.de
ETFs Investing in IDEXX Laboratories, Inc. Stocks - TradingView
IDXX: Idexx Laboratories Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Laboratories stock steadies after strong Q2 2026 results and raised outlook - AD HOC NEWS
IDEXX Laboratories stock holds firm as investors eye earnings history - ad-hoc-news.de
Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound? - Eastern Progress
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDEXX Laboratories stock holds firm after earnings beat - AD HOC NEWS
Resilient IDEXX Laboratories stock holds above $550 as earnings beat supports guidance - AD HOC NEWS
IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - Yahoo Finance
IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day - MarketWatch
IDEXX Laboratories Inc. (IDXX) Key Financial Ratios – Valuation, Profitability & More - Value Research
Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink? - webull.com
Insider Decision: Andrew Emerson Exercises Options At IDEXX Laboratories For $101K - Benzinga
IDEXX (NASDAQ: IDXX) CFO exercises 265 options at $178.26 - Stock Titan
IDEXX Laboratories stock holds high valuation as earnings outlook firms - Ad-hoc-news.de
Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now? - TradingView
IDEXX launches first dual-species point-of-care NT-proBNP test for cardiac disease in cats and dogs - DVM360
Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding - Yahoo Finance
Flossbach Von Storch SE Invests $9.09 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Danske Bank A S Buys New Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $665 - 富途牛牛
Resilient IDEXX Laboratories stock trades in the mid-$550s as investors weigh premium valuation and - Ad-hoc-news.de
IDXX (IDEXX Laboratories) Cash Flow from Operations : $1,372 Mil (TTM As of Jun. 2026) - GuruFocus
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
IDEXX Laboratories stock holds above the mid-$540s as valuation stays demanding - Ad-hoc-news.de
IDXX (IDEXX Laboratories) Cash From Discontinued Investing Activities : $0 Mil (TTM As of Jun. 2026) - GuruFocus
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999. - marketscreener.com
Plato Investment Management Ltd Takes $1.48 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution (NASDAQ:IDXX) - Seeking Alpha
Weekly Recap: AI diagnostics expansion and Barclays trims target to $710 - TradingView
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unpacking a 26.86% Potential Upside in the Diagnostics & Research Sector - DirectorsTalk Interviews
IDEXX Laboratories Inc (IDXX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Transamerica Large Core ESG's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
IDXX Stock Price and Chart — NASDAQ:IDXX - TradingView
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests - MarketBeat
IDEXX Laboratories, Inc. (IDXX) Analyst/Investor DaySlideshow (NASDAQ:IDXX) 2026-08-14 - Seeking Alpha
1.56%
0.48%
大文字化:
|
ボリューム (24 時間):